However, our subgroup analysis showed that hypercholesterolemia was significantly associated with graft failure only in recipients without mTOR inhibition, but no significant interaction was observed for the use of mTOR with the association between hypercholesterolemia and MACE. Here, MTOR is linked to familial hypercholesterolemia.